首页> 外文期刊>Przegld Menopauzalny: Menopause Review >Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause
【24h】

Vaginal dehydroepiandrosterone compared to other methods of treating vaginal and vulvar atrophy associated with menopause

机译:阴道脱氢硫酮与治疗与更年期相关的阴道和外阴萎缩的其他方法相比

获取原文
           

摘要

During the menopause, a fall in estrogen levels often leads to many unfavorable symptoms, including changes in the vascular and urogenital systems, in mood, and sleep. The symptoms of vulvovaginal atrophy are especially troublesome for menopausal women. These symptoms not only disturb the sexual sphere, but also functioning at work and in the family. Based on the literature, a review of contemporary methods of management in the case of symptoms of vulvar atrophy in menopausal women has been performed. The current methods of treating vulvovaginal atrophy in menopausal women are described. The pharmacology of the available dehydroepiandrosterone (DHEA) preparations, both oral and vaginal, was briefly analyzed. Own experiences of using DHEA are presented. Vaginal DHEA has been found to be an effective and safe treatment in menopausal women with symptoms of vaginal atrophy.
机译:在更年期期间,雌激素水平的下降通常导致许多不利的症状,包括血管和泌尿生殖系统的变化,情绪和睡眠。暴饮递萎缩的症状对于更年期妇女来说是特别麻烦的。这些症状不仅扰乱了性球,而且在工作和家庭中运作。基于文献,已经进行了对日期妇女的外阴萎缩症状当代管理方法的综述。描述了在更年期妇女中治疗潜水腺萎缩性萎缩的目前的方法。简要分析了可用的脱氢硫醚酮(DHEA)制剂的药理学,口服和阴道。展示了自己使用DHEA的经验。已被发现阴道DHEA是在未经许经期妇女的有效和安全的患有阴道萎缩的症状。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号